Antibody Evolution Machine

A new approach developed by Harvard Medical School researchers uses yeast to rapidly evolve synthetic antibody fragments called nanobodies with the aim to find variants that are effective at binding to selected antigens, including SARS-CoV-2. The antibodies are intended for use in diagnostic tests and disease treatments.

Read the full story:

Products You May Like

Articles You May Like

Same county tops healthiest US community ranking for third year in a row
AI-based smartphone apps to spot skin cancer endanger the public, experts warn
Cognitive Dissonance in the Medical Profession
Monkeypox: CDC Activates ‘Emergency Operations Center’; US To Offer More Vaccines
FDA advisers vote to include an Omicron-specific component for a coronavirus booster in the US

Leave a Reply

Your email address will not be published.